{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:11:28Z","timestamp":1788883888845,"version":"build-2803163510"},"reference-count":45,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This randomized controlled trial evaluated dexmedetomidine combined with remifentanil versus remifentanil alone for monitored anesthesia care during radiofrequency catheter ablation for atrial fibrillation. Between January and December 2023, 100 patients were stratified by age, sex, BMI, and atrial fibrillation type, then\u00a0randomly assigned (1:1, block size 4, sealed envelopes) to Group A (dexmedetomidine 1\u202f\u03bcg\/kg loading then 0.2\u20130.4\u202f\u03bcg\/kg\/h plus remifentanil,\n                    <jats:italic>n<\/jats:italic>\n                    \u00a0=\u00a050) or Group B (saline control plus remifentanil,\n                    <jats:italic>n<\/jats:italic>\n                    \u00a0=\u00a050). Baseline characteristics were comparable (all\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0&gt;\u00a00.05). Hemodynamic parameters were recorded at baseline (\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>0<\/jats:sub>\n                    ), 10\u202fmin after induction (\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>1<\/jats:sub>\n                    ), maintenance (\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>2<\/jats:sub>\n                    ), 10\u202fmin before surgery end (\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>3<\/jats:sub>\n                    ), and at surgery end (\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>4<\/jats:sub>\n                    ). Group A showed higher mean arterial pressure, cardiac index, and cardiac output at\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>1<\/jats:sub>\n                    \u2013\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>4<\/jats:sub>\n                    (\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0&lt;\u00a00.05), with lower heart rate and blood pressure (\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0&lt;\u00a00.05). Ramsay Sedation Score was higher at\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>3<\/jats:sub>\n                    \u2013\n                    <jats:italic>T<\/jats:italic>\n                    <jats:sub>4<\/jats:sub>\n                    (\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0&lt;\u00a00.05). Adverse reactions and inflammatory markers (IL-6, TNF-\u03b1, CRP) were attenuated postoperatively (\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0&lt;\u00a00.05). Dexmedetomidine combined with remifentanil provides superior hemodynamic stability, enhanced sedation, reduced inflammation, and fewer adverse events during atrial fibrillation ablation.\n                  <\/jats:p>","DOI":"10.1515\/biol-2025-1364","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:56:40Z","timestamp":1788883000000},"source":"Crossref","is-referenced-by-count":0,"title":["Effects of dexmedetomidine-remifentanil on hemodynamics and inflammatory responses in patients undergoing atrial fibrillation ablation"],"prefix":"10.1515","volume":"21","author":[{"given":"Lu","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Cardiology , Sixth Hospital of Wuhan Affiliated Hospital of Jianghan University , Wuhan 430015 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Clinical Anesthesiology , Tongji Medical College, Huazhong University of Science & Technology, (Wuhan Children\u2019s Hospital)\/ (Wuhan Maternal and Child Healthcare Hospital) , Wuhan 430015 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology , Sixth Hospital of Wuhan Affiliated Hospital of Jianghan University , Wuhan 430015 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqian","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology , Sixth Hospital of Wuhan Affiliated Hospital of Jianghan University , Wuhan 430015 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2026090815562118050_j_biol-2025-1364_ref_001","doi-asserted-by":"crossref","unstructured":"Chyou, JY, Barkoudah, E, Dukes, JW, Goldstein, LB, Joglar, JA, Lee, AM, et al.. Atrial fibrillation occurring during acute hospitalization: a scientific statement from the American Heart Association. Circulation 2023;147:676\u201398. https:\/\/doi.org\/10.1161\/CIR.0000000000001133.","DOI":"10.1161\/CIR.0000000000001147"},{"key":"2026090815562118050_j_biol-2025-1364_ref_002","doi-asserted-by":"crossref","unstructured":"Alonso, A, Almuwaqqat, Z, Chamberlain, A. Mortality in atrial fibrillation: is it changing? Trends Cardiovasc Med 2021;31:469\u201373. https:\/\/doi.org\/10.1016\/j.tcm.2020.10.010.","DOI":"10.1016\/j.tcm.2020.10.010"},{"key":"2026090815562118050_j_biol-2025-1364_ref_003","doi-asserted-by":"crossref","unstructured":"Bizhanov, KA, Abzaliyev, KB, Baimbetov, AK, Sarsenbayeva, AB, Lyan, E. Atrial fibrillation: epidemiology, pathophysiology, and clinical complications (literature review). J\u00a0Cardiovasc Electrophysiol 2023;34:153\u201365. https:\/\/doi.org\/10.1111\/jce.15759.","DOI":"10.1111\/jce.15759"},{"key":"2026090815562118050_j_biol-2025-1364_ref_004","doi-asserted-by":"crossref","unstructured":"Sagris, M, Vardas, EP, Theofilis, P, Antonopoulos, AS, Oikonomou, E, Tousoulis, D. Atrial fibrillation: pathogenesis, predisposing factors, and genetics. Int J Mol Sci 2021;23:6. https:\/\/doi.org\/10.3390\/ijms23010006.","DOI":"10.3390\/ijms23010006"},{"key":"2026090815562118050_j_biol-2025-1364_ref_005","doi-asserted-by":"crossref","unstructured":"Reddy, VY, Anter, E, Rackauskas, G, Peichl, P, Koruth, JS, Petru, J, et al.. Lattice-tip focal ablation catheter that toggles between radiofrequency and pulsed field energy to treat atrial fibrillation: a first-in-human trial. Circ Arrhythm Electrophysiol 2020;13:e008718. https:\/\/doi.org\/10.1161\/CIRCEP.120.008718.","DOI":"10.1161\/CIRCEP.120.008718"},{"key":"2026090815562118050_j_biol-2025-1364_ref_006","doi-asserted-by":"crossref","unstructured":"Parameswaran, R, Al-Kaisey, AM, Kalman, JM. Catheter ablation for atrial fibrillation: current indications and evolving technologies. Nat Rev Cardiol 2021;18:210\u201325. https:\/\/doi.org\/10.1038\/s41569-020-00451-x.","DOI":"10.1038\/s41569-020-00451-x"},{"key":"2026090815562118050_j_biol-2025-1364_ref_007","doi-asserted-by":"crossref","unstructured":"Reddy, VY, Peichl, P, Anter, E, Rackauskas, G, Petru, J, Funasako, M, et al.. A focal ablation catheter toggling between radiofrequency and pulsed field energy to treat atrial fibrillation. JACC Clin Electrophysiol 2023;9:1786\u2013801. https:\/\/doi.org\/10.1016\/j.jacep.2023.04.002.","DOI":"10.1016\/j.jacep.2023.04.002"},{"key":"2026090815562118050_j_biol-2025-1364_ref_008","doi-asserted-by":"crossref","unstructured":"Waranugraha, Y, Tsai, CT, Lin, LY. Indicator-guided high-power radiofrequency catheter ablation for atrial fibrillation: a systematic\u00a0review and meta-analysis study. Curr Cardiol Rep 2023;25:1397\u2013414. https:\/\/doi.org\/10.1007\/s11886-023-01968-6.","DOI":"10.1007\/s11886-023-01968-6"},{"key":"2026090815562118050_j_biol-2025-1364_ref_009","doi-asserted-by":"crossref","unstructured":"Breithardt, G, Borggrefe, M. The dawn of radiofrequency catheter ablation for cardiac arrhythmias. Heart Rhythm 2021;18:485\u20136. https:\/\/doi.org\/10.1016\/j.hrthm.2020.11.030.","DOI":"10.1016\/j.hrthm.2020.11.030"},{"key":"2026090815562118050_j_biol-2025-1364_ref_010","doi-asserted-by":"crossref","unstructured":"Tabaja, C, Younis, A, Hussein, AA, Taigen, TL, Nakagawa, H, Saliba, WI, et al.. Catheter-based electroporation: a novel technique for catheter ablation of cardiac arrhythmias. JACC Clin Electrophysiol 2023;9:2008\u201323. https:\/\/doi.org\/10.1016\/j.jacep.2023.03.014.","DOI":"10.1016\/j.jacep.2023.03.014"},{"key":"2026090815562118050_j_biol-2025-1364_ref_011","doi-asserted-by":"crossref","unstructured":"Osorio, J, Hussein, AA, Delaughter, MC, Monir, G, Natale, A, Dukkipati, S, et al.. Very high-power short-duration, temperature-controlled radiofrequency ablation in paroxysmal atrial fibrillation: the prospective multicenter Q-FFICIENCY trial. JACC Clin Electrophysiol 2023;9:468\u201380. https:\/\/doi.org\/10.1016\/j.jacep.2022.10.019.","DOI":"10.1016\/j.jacep.2022.10.019"},{"key":"2026090815562118050_j_biol-2025-1364_ref_012","doi-asserted-by":"crossref","unstructured":"Persson Tasbihgou, SR, Barends, CRM, Absalom, AR. The role of dexmedetomidine in neurosurgery. Best Pract Res Clin Anaesthesiol 2021;35:221\u20139. https:\/\/doi.org\/10.1016\/j.bpa.2020.10.002.","DOI":"10.1016\/j.bpa.2020.10.002"},{"key":"2026090815562118050_j_biol-2025-1364_ref_013","doi-asserted-by":"crossref","unstructured":"Persson, ND\u00c5, Uusalo, P, Nedergaard, M, Lohela, TJ, Lilius, TO. Could dexmedetomidine be repurposed as a glymphatic enhancer? Trends Pharmacol Sci 2022;43:1030\u201340. https:\/\/doi.org\/10.1016\/j.tips.2022.09.007.","DOI":"10.1016\/j.tips.2022.09.007"},{"key":"2026090815562118050_j_biol-2025-1364_ref_014","doi-asserted-by":"crossref","unstructured":"Poon, WH, Ling, RR, Yang, IX, Luo, H, Kofidis, T, MacLaren, G, et al.. Dexmedetomidine for adult cardiac surgery: a systematic review, meta-analysis and trial sequential analysis. Anaesthesia 2023;78:371\u201380. https:\/\/doi.org\/10.1111\/anae.15947.","DOI":"10.1111\/anae.15947"},{"key":"2026090815562118050_j_biol-2025-1364_ref_015","doi-asserted-by":"crossref","unstructured":"Hughes, LM, Irwin, MG, Nestor, CC. Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review. Anaesthesia 2023;78:620\u20135. https:\/\/doi.org\/10.1111\/anae.15952.","DOI":"10.1111\/anae.15952"},{"key":"2026090815562118050_j_biol-2025-1364_ref_016","doi-asserted-by":"crossref","unstructured":"Cort\u00ednez, LI, Anderson, BJ. Harnessing remifentanil adverse effects. Paediatr Anaesth 2021;31:513\u201314. https:\/\/doi.org\/10.1111\/pan.14159.","DOI":"10.1111\/pan.14159"},{"key":"2026090815562118050_j_biol-2025-1364_ref_017","doi-asserted-by":"crossref","unstructured":"Nimmo, AF, Shinde, S, Absalom, AR. Remifentanil: achieving a \u2019standard concentration\u2019: a reply. Anaesthesia 2022;77:944. https:\/\/doi.org\/10.1111\/anae.15749.","DOI":"10.1111\/anae.15749"},{"key":"2026090815562118050_j_biol-2025-1364_ref_018","doi-asserted-by":"crossref","unstructured":"Birgenheier, NM, Stuart, AR, Egan, TD. Soft drugs in anesthesia: remifentanil as prototype to modern anesthetic drug development. Curr Opin Anaesthesiol 2020;33:499\u2013505. https:\/\/doi.org\/10.1097\/ACO.0000000000000879.","DOI":"10.1097\/ACO.0000000000000879"},{"key":"2026090815562118050_j_biol-2025-1364_ref_019","doi-asserted-by":"crossref","unstructured":"Shabani, Y, Moshiri, E, Modir, H, Kamali, A, Almasi-Hashiani, A. Effects of ketamine, granisetron and dexmedetomidine on postoperative shivering and hemodynamic changes after general anesthesia: a double-blind randomized clinical trial. Med Gas Res 2024;14:19\u201325. https:\/\/doi.org\/10.4103\/2045-9912.374389.","DOI":"10.4103\/2045-9912.374389"},{"key":"2026090815562118050_j_biol-2025-1364_ref_020","doi-asserted-by":"crossref","unstructured":"Modir, H, Hafez-Alsehe, N, Almasi-Hashiani, A, Kamali, A. Effects of dexmedetomidine, fentanyl and magnesium sulfate added to ropivacaine on sensory and motor blocks in lower abdominal surgery: a randomized clinical trial. Med Gas Res 2024;14:102\u20137. https:\/\/doi.org\/10.4103\/2045-9912.385947.","DOI":"10.4103\/2045-9912.385947"},{"key":"2026090815562118050_j_biol-2025-1364_ref_021","doi-asserted-by":"crossref","unstructured":"Abedzadeh, E, Modir, H, Pazooki, S, Barsari, FZ, Almasi-Hashiani, A. Comparison of adding magnesium sulfate, dexmedetomidine and ondansetron to lidocaine for gargling before laryngoscopy and endotracheal intubation to prevent sore throat: a randomized clinical trial. Med Gas Res 2024;14:54\u201360. https:\/\/doi.org\/10.4103\/2045-9912.372664.","DOI":"10.4103\/2045-9912.372664"},{"key":"2026090815562118050_j_biol-2025-1364_ref_022","doi-asserted-by":"crossref","unstructured":"Zhang, Y, Zhao, L, Lv, L, Li, S. Retrospective analysis of remifentanil combined with dexmedetomidine intravenous anesthesia combined with brachial plexus block on shoulder arthroscopic surgery in elderly patients. Pak J Med Sci 2022;38:1546\u201351. https:\/\/doi.org\/10.12669\/pjms.38.6.5724.","DOI":"10.12669\/pjms.38.6.5724"},{"key":"2026090815562118050_j_biol-2025-1364_ref_023","doi-asserted-by":"crossref","unstructured":"Yan, X, Ghosh, P, Chakraborty, B. Sample size calculation based on precision for pilot sequential multiple assignment randomized trial (SMART). Biom J 2021;63:247\u201371. https:\/\/doi.org\/10.1002\/bimj.201900364.","DOI":"10.1002\/bimj.201900364"},{"key":"2026090815562118050_j_biol-2025-1364_ref_024","doi-asserted-by":"crossref","unstructured":"Joglar, JA, Chung, MK, Armbruster, AL, Benjamin, EJ, Chyou, JY, Cronin, EM, et al.. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:1-156. https:\/\/doi.org\/10.1161\/CIR.0000000000001193.","DOI":"10.1161\/CIR.0000000000001218"},{"key":"2026090815562118050_j_biol-2025-1364_ref_025","doi-asserted-by":"crossref","unstructured":"Sowder, T, Sayed, D, Concannon, T, Pew, SH, Strand, NH, Abd-Elsayed, A, et al.. American Society of Pain and Neuroscience (ASPN) guidelines for radiofrequency ablative procedures in patients with implanted devices. J\u00a0Pain Res 2023;16:3693\u2013706. https:\/\/doi.org\/10.2147\/JPR.S419594.","DOI":"10.2147\/JPR.S419594"},{"key":"2026090815562118050_j_biol-2025-1364_ref_026","doi-asserted-by":"crossref","unstructured":"Avci, S, Bayram, B, Inan\u00e7, G, G\u00f6ren, NZ, Oniz, A, Ozgoren, M, et al.. Evaluation of the compliance between EEG monitoring (Bispectral index\u2122) and Ramsey Sedation Scale to measure the depth of sedation in the patients who underwent procedural sedation and analgesia in the emergency department. Ulus Travma Acil Cerrahi Derg 2019;25:447\u201352. https:\/\/doi.org\/10.5505\/tjtes.2018.32627.","DOI":"10.5505\/tjtes.2018.32627"},{"key":"2026090815562118050_j_biol-2025-1364_ref_027","doi-asserted-by":"crossref","unstructured":"He, Y, Tang, Z, Sun, G, Cai, C, Wang, Y, Yang, G, et al.. Effectiveness of a mindfulness meditation app based on an electroencephalography-based brain-computer interface in radiofrequency catheter ablation for patients with atrial fibrillation: pilot randomized controlled trial. JMIR mHealth uHealth 2023;11:e44855. https:\/\/doi.org\/10.2196\/44855.","DOI":"10.2196\/44855"},{"key":"2026090815562118050_j_biol-2025-1364_ref_028","doi-asserted-by":"crossref","unstructured":"Ha\u00efssaguerre, M. Toward radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm 2021;18:2219\u201320. https:\/\/doi.org\/10.1016\/j.hrthm.2021.09.034.","DOI":"10.1016\/j.hrthm.2021.09.034"},{"key":"2026090815562118050_j_biol-2025-1364_ref_029","doi-asserted-by":"crossref","unstructured":"Xiao, M, Jiang, CF, Gao, Q, Pan, J, Zhang, H, Wu, SN, et al.. Effect of dexmedetomidine on cardiac surgery patients. J\u00a0Cardiovasc Pharmacol 2023;81:104\u201313. https:\/\/doi.org\/10.1097\/FJC.0000000000001384.","DOI":"10.1097\/FJC.0000000000001384"},{"key":"2026090815562118050_j_biol-2025-1364_ref_030","doi-asserted-by":"crossref","unstructured":"Takahashi, K, Yoshikawa, Y, Kanda, M, Hirata, N, Yamakage, M. Dexmedetomidine as a cardioprotective drug: a narrative review. J\u00a0Anesth 2023;37:961\u201370. https:\/\/doi.org\/10.1007\/s00540-023-03261-w.","DOI":"10.1007\/s00540-023-03261-w"},{"key":"2026090815562118050_j_biol-2025-1364_ref_031","doi-asserted-by":"crossref","unstructured":"Momeni, M, Khalifa, C, Lemaire, G, Watremez, C, Tircoveanu, R, Van Dyck, M, et al.. Propofol plus low-dose dexmedetomidine infusion and postoperative delirium in older patients undergoing cardiac surgery. Br J Anaesth 2021;126:665\u201373. https:\/\/doi.org\/10.1016\/j.bja.2020.10.041.","DOI":"10.1016\/j.bja.2020.10.041"},{"key":"2026090815562118050_j_biol-2025-1364_ref_032","doi-asserted-by":"crossref","unstructured":"De Cassai, A, Boscolo, A, Geraldini, F, Zarantonello, F, Pettenuzzo, T, Pasin, L, et al.. Effect of dexmedetomidine on hemodynamic responses to tracheal intubation: a meta-analysis with meta-regression and trial sequential analysis. J\u00a0Clin Anesth 2021;72:110287. https:\/\/doi.org\/10.1016\/j.jclinane.2021.110287.","DOI":"10.1016\/j.jclinane.2021.110287"},{"key":"2026090815562118050_j_biol-2025-1364_ref_033","doi-asserted-by":"crossref","unstructured":"Unchiti, K, Leurcharusmee, P, Samerchua, A, Pipanmekaporn, T, Chattipakorn, N, Chattipakorn, SC. The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: evidence from in\u00a0vitro and in\u00a0vivo studies. Eur J Neurosci 2021;54:7006\u201347. https:\/\/doi.org\/10.1111\/ejn.15474.","DOI":"10.1111\/ejn.15474"},{"key":"2026090815562118050_j_biol-2025-1364_ref_034","doi-asserted-by":"crossref","unstructured":"Burlacu, CC, Neag, MA, Mitre, AO, Sirbu, AC, Badulescu, AV, Buzoianu, AD. The role of miRNAs in dexmedetomidine\u2019s neuroprotective effects against brain disorders. Int J Mol Sci 2022;23:5452. https:\/\/doi.org\/10.3390\/ijms23105452.","DOI":"10.3390\/ijms23105452"},{"key":"2026090815562118050_j_biol-2025-1364_ref_035","doi-asserted-by":"crossref","unstructured":"Carvalho, H, Kalmar, A, Saxena, S. Remifentanil vs neuromuscular blockers during rapid sequence intubation among patients at risk of aspiration. JAMA 2023;329:1517\u201318. https:\/\/doi.org\/10.1001\/jama.2023.3491.","DOI":"10.1001\/jama.2023.3491"},{"key":"2026090815562118050_j_biol-2025-1364_ref_036","doi-asserted-by":"crossref","unstructured":"Thomas, A, Ullrich, M. Dexmedetomidine: a sedation alternative in the intensive care setting. Crit Care Nurs Q 2023;46:271\u20136. https:\/\/doi.org\/10.1097\/CNQ.0000000000000458.","DOI":"10.1097\/CNQ.0000000000000458"},{"key":"2026090815562118050_j_biol-2025-1364_ref_037","doi-asserted-by":"crossref","unstructured":"Tang, T, Wagle, R, Hasoon, J, Markan, S, Nguyen, A. Dexmedetomidine-induced diabetes insipidus during coronary artery bypass graft surgery. Anaesthesiol Intensive Ther 2023;55:237\u20139. https:\/\/doi.org\/10.5114\/ait.2023.130859.","DOI":"10.5114\/ait.2023.130859"},{"key":"2026090815562118050_j_biol-2025-1364_ref_038","doi-asserted-by":"crossref","unstructured":"Long, B, Gottlieb, M. Dexmedetomidine in critically ill adults requiring noninvasive ventilation. Acad Emerg Med 2022;29:384\u20136. https:\/\/doi.org\/10.1111\/acem.14368.","DOI":"10.1111\/acem.14368"},{"key":"2026090815562118050_j_biol-2025-1364_ref_039","doi-asserted-by":"crossref","unstructured":"Scott, MC, Haase, CM, Olson, SD, CoxJrCS. Dexmedetomidine alters the inflammatory profile of rat microglia in\u00a0vitro. Neurocritical Care 2023;38:688\u201397. https:\/\/doi.org\/10.1007\/s12028-022-01638-5.","DOI":"10.1007\/s12028-022-01638-5"},{"key":"2026090815562118050_j_biol-2025-1364_ref_040","doi-asserted-by":"crossref","unstructured":"Subramaniam, K, Sciortino, C, Ruppert, K, Monroe, A, Esper, S, Boisen, M, et al.. Remifentanil and perioperative glycaemic response in cardiac surgery: an open-label randomised trial. Br J Anaesth 2020;124:684\u201392. https:\/\/doi.org\/10.1016\/j.bja.2020.01.028.","DOI":"10.1016\/j.bja.2020.01.028"},{"key":"2026090815562118050_j_biol-2025-1364_ref_041","unstructured":"Izgi, M, Basaran, B, Bayir, T, Akca, B, Celebioglu, B. The effect of remifentanil and dexmedetomidine on dynamic thiol\/disulfide balance in patients undergoing coronary artery bypass surgery: a prospective case-control study. Eur Rev Med Pharmacol Sci 2023;27:9050\u20137. https:\/\/doi.org\/10.26355\/eurrev_202310_33930."},{"key":"2026090815562118050_j_biol-2025-1364_ref_042","doi-asserted-by":"crossref","unstructured":"Beloeil, H, Garot, M, Lebuffe, G, Gerbaud, A, Bila, J, Cuvillon, P, et al.. Balanced opioid-free anesthesia with dexmedetomidine versus balanced anesthesia with remifentanil for major or intermediate noncardiac surgery. Anesthesiology 2021;134:541\u201351. https:\/\/doi.org\/10.1097\/ALN.0000000000003725.","DOI":"10.1097\/ALN.0000000000003725"},{"key":"2026090815562118050_j_biol-2025-1364_ref_043","doi-asserted-by":"crossref","unstructured":"Chow, JJ, Beckmann, JS. Remifentanil-food choice follows predictions of relative subjective value. Drug Alcohol Depend 2021;218:108369. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108369.","DOI":"10.1016\/j.drugalcdep.2020.108369"},{"key":"2026090815562118050_j_biol-2025-1364_ref_044","doi-asserted-by":"crossref","unstructured":"Wylie, N, Beale, L, Westley, I. Consistency of remifentanil concentrations in propofol-remifentanil infusions: a laboratory-based study. Paediatr Anaesth 2022;32:727\u201331. https:\/\/doi.org\/10.1111\/pan.14427.","DOI":"10.1111\/pan.14427"},{"key":"2026090815562118050_j_biol-2025-1364_ref_045","doi-asserted-by":"crossref","unstructured":"Abad-Torrent, A, Mart\u00ednez-V\u00e1zquez, P, Somma, J, Hsu, YW, Izquierdo, E. Remifentanil pharmacodynamics during conscious sedation using algometry: a more clinically relevant pharmacodynamical model. Br J Anaesth 2022;129:868\u201378. https:\/\/doi.org\/10.1016\/j.bja.2022.08.026.","DOI":"10.1016\/j.bja.2022.08.026"}],"container-title":["Open Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1364\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1364\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:56:52Z","timestamp":1788883012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1364\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,9,8]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/biol-2025-1364"],"URL":"https:\/\/doi.org\/10.1515\/biol-2025-1364","relation":{},"ISSN":["2391-5412"],"issn-type":[{"value":"2391-5412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20251364"}}